These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25721147)

  • 1. Response.
    Fleming TR
    Clin Trials; 2015 Feb; 12(1):21-3. PubMed ID: 25721147
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary: data monitoring confidentiality and FDA transparency.
    London AJ
    Clin Trials; 2015 Feb; 12(1):12-4. PubMed ID: 25525073
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary: preserving confidentiality of interim data.
    Chuang-Stein C; Jiang Q; Marchenko O
    Clin Trials; 2015 Feb; 12(1):18-20. PubMed ID: 25480540
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary: confidentiality of interim trial data-the emerging crisis.
    Nissen SE
    Clin Trials; 2015 Feb; 12(1):15-7. PubMed ID: 25525072
    [No Abstract]   [Full Text] [Related]  

  • 5. Protecting the confidentiality of interim data: addressing current challenges.
    Fleming TR
    Clin Trials; 2015 Feb; 12(1):5-11. PubMed ID: 25475877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Data monitoring committees. Third pillar in the methodical conduct of clinical trials].
    Fischer T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):793-6. PubMed ID: 18563280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring data on data monitoring.
    Ellenberg SS
    Clin Trials; 2004 Feb; 1(1):6-8. PubMed ID: 16281457
    [No Abstract]   [Full Text] [Related]  

  • 8. Assuring trial safety for children.
    Howie S; Mueller J; Whittle H
    Lancet; 2008 Jul; 372(9632):30. PubMed ID: 18603156
    [No Abstract]   [Full Text] [Related]  

  • 9. Data safety monitoring boards: a word from a sponsor (NHLBI).
    Mondoro TH
    Transfusion; 2009 Aug; 49(8):1537-9. PubMed ID: 19413736
    [No Abstract]   [Full Text] [Related]  

  • 10. Planning and core analyses for periodic aggregate safety data reviews.
    Xia HA; Crowe BJ; Schriver RC; Oster M; Hall DB
    Clin Trials; 2011 Apr; 8(2):175-82. PubMed ID: 21270142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring reportable events and unanticipated problems: the PHAROS and PREDICT studies of Huntington disease.
    Erwin C; Hersch S;
    IRB; 2007; 29(3):11-6. PubMed ID: 17847637
    [No Abstract]   [Full Text] [Related]  

  • 12. A domain model of a clinical reading center - Design and implementation.
    Lotz G; Peters T; Zrenner E; Wilke R
    Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():4530-3. PubMed ID: 21095788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The FDA's new oncology office.
    Pazdur R
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):612-3. PubMed ID: 16167044
    [No Abstract]   [Full Text] [Related]  

  • 14. The Absence of an Ideal Observer: Why Some Clinical Trials May Not Be What We Think They Are.
    Packer M
    Circulation; 2017 Sep; 136(12):1085-1086. PubMed ID: 28923903
    [No Abstract]   [Full Text] [Related]  

  • 15. University of Pennsylvania 10th annual conference on statistical issues in clinical trials: Current issues regarding data and safety monitoring committees in clinical trials (afternoon panel session).
    Dickersin K; Dixon D; Ferris F; Goldberg J; Kimmel S; Lachin J
    Clin Trials; 2018 Aug; 15(4):366-385. PubMed ID: 30021497
    [No Abstract]   [Full Text] [Related]  

  • 16. Striding forward or getting too big for their boots? The developing role of data monitoring committees in clinical trials.
    Tharmanathan P; Calvert MJ; Freemantle N
    J Clin Pharm Ther; 2006 Apr; 31(2):111-8. PubMed ID: 16635044
    [No Abstract]   [Full Text] [Related]  

  • 17. Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative.
    Calis KA; Archdeacon P; Bain R; DeMets D; Donohue M; Elzarrad MK; Forrest A; McEachern J; Pencina MJ; Perlmutter J; Lewis RJ
    Clin Trials; 2017 Aug; 14(4):342-348. PubMed ID: 28503947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data monitoring (and safety) committees--what are they and why do we need them? Primary Care Alliance for Clinical Trials (PACT) Network.
    Pirotta M; Chondros P;
    Aust Fam Physician; 2004 Nov; 33(11):950-1, 956. PubMed ID: 15584339
    [No Abstract]   [Full Text] [Related]  

  • 19. Data Sharing: An Ethical and Scientific Imperative.
    Bauchner H; Golub RM; Fontanarosa PB
    JAMA; 2016 Mar 22-29; 315(12):1237-9. PubMed ID: 27002444
    [No Abstract]   [Full Text] [Related]  

  • 20. Stopping rules for clinical trials.
    Whitehead J
    Control Clin Trials; 2004 Feb; 25(1):69-70; author reply 71-2. PubMed ID: 14980750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.